COYA
Price
$5.86
Change
+$0.15 (+2.63%)
Updated
May 23, 04:59 PM (EDT)
Capitalization
95.5M
81 days until earnings call
XNCR
Price
$7.57
Change
-$0.12 (-1.56%)
Updated
May 23, 04:59 PM (EDT)
Capitalization
547.3M
68 days until earnings call
Interact to see
Advertisement

COYA vs XNCR

Header iconCOYA vs XNCR Comparison
Open Charts COYA vs XNCRBanner chart's image
Coya Therapeutics
Price$5.86
Change+$0.15 (+2.63%)
Volume$200
Capitalization95.5M
Xencor
Price$7.57
Change-$0.12 (-1.56%)
Volume$16.02K
Capitalization547.3M
COYA vs XNCR Comparison Chart
Loading...
COYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XNCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
COYA vs. XNCR commentary
May 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COYA is a Hold and XNCR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
May 24, 2025
Stock price -- (COYA: $5.71 vs. XNCR: $7.69)
Brand notoriety: COYA and XNCR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: COYA: 65% vs. XNCR: 100%
Market capitalization -- COYA: $95.5M vs. XNCR: $547.3M
COYA [@Biotechnology] is valued at $95.5M. XNCR’s [@Biotechnology] market capitalization is $547.3M. The market cap for tickers in the [@Biotechnology] industry ranges from $307B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COYA’s FA Score shows that 0 FA rating(s) are green whileXNCR’s FA Score has 1 green FA rating(s).

  • COYA’s FA Score: 0 green, 5 red.
  • XNCR’s FA Score: 1 green, 4 red.
According to our system of comparison, both COYA and XNCR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COYA’s TA Score shows that 2 TA indicator(s) are bullish while XNCR’s TA Score has 4 bullish TA indicator(s).

  • COYA’s TA Score: 2 bullish, 6 bearish.
  • XNCR’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, XNCR is a better buy in the short-term than COYA.

Price Growth

COYA (@Biotechnology) experienced а -2.73% price change this week, while XNCR (@Biotechnology) price change was -6.22% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.05%. For the same industry, the average monthly price growth was +3.15%, and the average quarterly price growth was -3.91%.

Reported Earning Dates

COYA is expected to report earnings on Aug 12, 2025.

XNCR is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Biotechnology (+1.05% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
XNCR($547M) has a higher market cap than COYA($95.5M). COYA YTD gains are higher at: -0.349 vs. XNCR (-66.536). COYA has higher annual earnings (EBITDA): -11.33M vs. XNCR (-161.68M). XNCR has more cash in the bank: 470M vs. COYA (31.1M). XNCR has higher revenues than COYA: XNCR (127M) vs COYA (9.55M).
COYAXNCRCOYA / XNCR
Capitalization95.5M547M17%
EBITDA-11.33M-161.68M7%
Gain YTD-0.349-66.5361%
P/E RatioN/AN/A-
Revenue9.55M127M8%
Total Cash31.1M470M7%
Total DebtN/A67.8M-
FUNDAMENTALS RATINGS
XNCR: Fundamental Ratings
XNCR
OUTLOOK RATING
1..100
4
VALUATION
overvalued / fair valued / undervalued
1..100
79
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
96
P/E GROWTH RATING
1..100
4
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
COYAXNCR
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
73%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 5 days ago
89%
Bullish Trend 9 days ago
71%
Declines
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 17 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
69%
Aroon
ODDS (%)
N/A
Bearish Trend 3 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
COYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XNCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JAGRX59.500.11
+0.19%
Janus Henderson VIT Research Instl
HSWFX20.26N/A
N/A
Hartford Schroders International Stk F
AICGX36.14N/A
N/A
American Century Discplnd Cor Val R5
FTZFX51.68N/A
N/A
FullerThaler Behvrll Uncnstd Eq R6
AIOOX11.42N/A
N/A
Aristotle/Saul Global Equity I-2

COYA and

Correlation & Price change

A.I.dvisor indicates that over the last year, COYA has been loosely correlated with NTLA. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if COYA jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COYA
1D Price
Change %
COYA100%
+0.71%
NTLA - COYA
37%
Loosely correlated
+2.83%
KNSA - COYA
36%
Loosely correlated
-0.65%
EYPT - COYA
35%
Loosely correlated
-4.60%
XNCR - COYA
34%
Loosely correlated
+2.26%
SNDX - COYA
34%
Loosely correlated
+1.50%
More

XNCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, XNCR has been loosely correlated with RCKT. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if XNCR jumps, then RCKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XNCR
1D Price
Change %
XNCR100%
+2.26%
RCKT - XNCR
60%
Loosely correlated
N/A
CRNX - XNCR
58%
Loosely correlated
+0.53%
ERAS - XNCR
58%
Loosely correlated
N/A
BEAM - XNCR
56%
Loosely correlated
N/A
ACLX - XNCR
54%
Loosely correlated
-0.50%
More